ModelEdge

Pharmaceutical Product Development, LLC
0001003124
Filing Type8-K
Filing Date12/4/2011
Updated12/5/11, 8:39 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Amendments to Articles of Incorporation or Bylaws
EX-3.1AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY
EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Amendments to Articles of Incorporation or Bylaws